Lantus Clinical Trials and Research Studies

Paid Clinical Trials and Focus Groups


Find Paid Clinical Trials

Paid Clinical Trials - : Lantus

Top of Directory » All Categories » by Drug Type » Lantus



  • Self Titration With Apidra to Reach Target Study (START)

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: insulin glargine;   Drug: Apidra (insulin glulisine)
    Sponsor:   Sanofi-Aventis
    Recruiting - verified November 2009
  • A Phase IIb 78-week Study in Patients on a Basal Insulin +/- Metformin and/or Sulfonylurea and Are Not at Goal to Add BI 10773 vs. Placebo

    Condition:   Diabetes Mellitus, Type 2
    Intervention:   Drug: BI 10773
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Recruiting - verified November 2009
  • Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: NN1250;   Drug: NN1250;   Drug: insulin glargine
    Sponsor:   Novo Nordisk
    Not yet recruiting - verified September 2009
  • Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Type 1 Diabetics

    Condition:   Diabetes Mellitus, Type 1
    Interventions:   Drug: NN1250;   Drug: insulin glargine
    Sponsor:   Novo Nordisk
    Recruiting - verified November 2009
  • A Study Comparing the Pharmacodynamic Properties of Insulin VIAJECT™, Regular Human Insulin, and Insulin Lispro

    Condition:   Diabetes Mellitus
    Interventions:   Drug: Regular Human Insulin;   Drug: Lispro;   Drug: VIAject;   Drug: VIAject 50%;   Drug: VIAject/Insulin glargine;   Drug: Insulin Glargine/VIAject
    Sponsor:   Biodel
    Completed - verified October 2009
    • Menu
    Find Paid Clinical Trials